Epstein Becker Green provided legal regulatory guidance to a pharmaceutical company on the commercial launch of a new medication that is a controlled substance subject to DEA regulation.
Epstein Becker Green provided legal regulatory guidance to a pharmaceutical company on the commercial launch of a new medication that is a controlled substance subject to DEA regulation.